Liposome-encapsulated doxorubicin citrate (Myocet) for treatment of recurrent epithelial ovarian cancer-Reference-Cited by-同舟云学术

Liposome-encapsulated doxorubicin citrate (Myocet) for treatment of recurrent epithelial ovarian cancer

Published:2014-01 Issue:1 Volume:25 Page:101-105
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Eitan Ram,Fishman Ami,Meirovitz Michai,Goldenberg Hadassah,Amit Amnon,Koren Claude,Schneider Yulia,Rosengarten Ora,Neuman Avivit,Keren-Rosenberg Shoshanna,Safra Tamar

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference9 articles.

1. Cancer statistics, 2009.;Jemal;CA Cancer J Clin,2009

2. Recurrent ovarian cancer.;Tummala;Clin Adv Hematol Oncol,2005

3. Epidemiology of ovarian cancer.;Permuth-Wey;Methods Mol Biol,2009

4. Achievements and unmet needs in the management of advanced ovarian cancer.;Guarneri;Gynecol Oncol,2010

5. Impact of doxorubicin on survival in advanced ovarian cancer.;AHern;J Clin Oncol,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy;Smart Medicine;2024-01-30

2. Fabrication design, process technologies, and convolutions in the scale-up of nanotherapeutic delivery systems;Nanoparticle Therapeutics;2022

3. Liposomes: An Emerging Approach for the Treatment of Cancer;Current Pharmaceutical Design;2021-08-04

4. A brief overview about the use of different bioactive liposome-based drug delivery systems in Peritoneal Dialysis and some other diseases;Nano Express;2021-05-12

5. Nanomedicine review: clinical developments in liposomal applications;Cancer Nanotechnology;2019-12